Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04911361 · ClinicalTrials.gov registry record · Phase 4
The DEPOT Study (Dry Eye Prescription Options for Therapy)
A Phase 4 study, sponsored by Research Insight.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT04911361 is a Phase 4 study that has completed, run by Research Insight. The registered enrollment target is 50 participants.
The verdict
NCT04911361, a Phase 4 study, has completed, sponsored by Research Insight.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
Assessing DEXTENZA efficacy and safety when placed within the lower eyelid canaliculus for dry eye flares in comparison to topical loteprednol suspension.
Interventions
- DRUG Dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-08-10 |
| Est. Completion | 2021-12-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04911361
The ClinicalTrials.gov registry entry for NCT04911361 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Research Insight, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexamethasone is the first listed.
NCT04911361 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04911361 about?
NCT04911361 is a clinical study titled "The DEPOT Study (Dry Eye Prescription Options for Therapy)". Assessing DEXTENZA efficacy and safety when placed within the lower eyelid canaliculus for dry eye flares in comparison to topical loteprednol suspension.
What is the current status of trial NCT04911361?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2021-08-10. Estimated completion is 2021-12-28.
What interventions are being tested in trial NCT04911361?
The interventions under investigation include: Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT04911361?
This trial is sponsored by Research Insight, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.